Download this Paper Open PDF in Browser

The Impact of Marijuana Pharmaceuticals

6 Pages Posted: 16 Sep 2013  

John Robert Alfino

Independent

Date Written: September 15, 2013

Abstract

FDA will soon approve Sativex, the first marijuana-based pharmaceutical. Sativex is a tipping point in the marijuana law and the politics of strict prohibition. The reclassification of marijuana under the Controlled Substances Act is in the financial interests of the American pharmaceutical industry. The availability of marijuana-based, or synthetic cannabinoid-based, pharmaceuticals will change the politics of marijuana prohibition.

Keywords: marijuana, Sativex, cannabinoid

Suggested Citation

Alfino, John Robert, The Impact of Marijuana Pharmaceuticals (September 15, 2013). Available at SSRN: https://ssrn.com/abstract=2326245 or http://dx.doi.org/10.2139/ssrn.2326245

John Robert Alfino (Contact Author)

Independent ( email )

No Address Available

Paper statistics

Downloads
40
Abstract Views
187